top of page
All Posts


FDA’s New Lens on AI/ML Devices
Artificial intelligence and machine learning (AI/ML) are no longer “future trends” in Medtech, they are here, and the FDA is moving...
Nathan Piland
Aug 282 min read


Tariff Whiplash in MedTech: Why Pricing is Now a Strategic Imperative, Not Just a Financial Headache
The global MedTech industry woke up this week to the kind of headline that rattles balance sheets and boardrooms: The U.S. and China...
Nathan Piland
Aug 253 min read


Malaysia’s MedTech Momentum: Why Strategics Are Doubling Down
While headlines often spotlight India or China in MedTech conversations, a quieter powerhouse has been building strength and focus for decades. During recent conversations at WHX Miami and my annual visit to Malaysia, one insight was clear: Malaysia is no longer just an emerging option, it’s a strategic MedTech hub.
Nathan Piland
Aug 252 min read


Navigating the Labyrinth: Creative Strategies for Start-ups in MedTech
In the competitive realm of Medtech, creativity isn't just an advantage—it's a necessity. From crafting compelling narratives to forging str
Nathan Piland
Apr 27, 20243 min read
bottom of page